 |
Page History
...
Welcome and Opening Comments
Dr. Farahani is the senior program director of data science, imaging, and AI at the National Heart, Lung, and Blood Institute. He's on detail at NCI CBIIT as a program director for imaging informatics and serves as the federal lead for several imaging projects, including the MIDI Initiative.
Session 1: Report of the MIDI Task Group - Best Practices and Recommendations
Session Chair: David Clunie, MBBS, PixelMed, LLC
In this session, David Clunie, chair of the MIDI Task Group, will summarize the best practices and recommendations included in the task group's report, recently available in pre-print, followed by a question and answer period.
Session 2: Tools for Conventional Approaches to De-Identification
Session Chair: Fred Prior, PhD, University of Arkansas for Medical Sciences
...
Session 4: Industry Approaches to De-Identification
Session chair: Keyvan Farahani, PhD, Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health
Industry has a role to play in de-identification, developing tools that protect human identity in medical images. This session will feature presentations by industry groups that examine their approaches and offerings.
Closing Remarks
David Clunie, MBBS, PixelMed, Inc.
DAY 2, May 23, 2023 (10:00 am to 2:00 pm EDT)
Welcome and Recap
David Clunie, MBBS, PixelMed, LLC
Session 5: Pathology Whole Slide Image De-Identification
Session chair: Adam Taylor, PhD, Sage Bionetworks
In this session, researchers will discuss pathology whole slide image de-identification.
...
Session 7: The Role of Artificial Intelligence in De-Identification
Session chair: Judy Wawira Gichoya, MD, MS, Emory University
In this session, researchers discuss the utility and risk of using algorithms from machine learning (ML) and artificial intelligence (AI) to de-identify medical images.
Session 8: Panel Discussion
Session chair: Jürgen Klenk, PhD, Deloitte Consulting LLP
Discussion of the approaches and challenges identified during the workshop and opportunities for the future.
Closing Remarks
David Clunie, MBBS, PixelMed, LLC
Keyvan Farahani, PhD, NCI
